J.P. Morgan Annual Healthcare Conference, San Francisco, USA - Shorla Oncology: A Leader in Innovative Oncology Solutions

LATEST NEWS

Shorla Oncology attending Asembia 2025

Shorla Oncology is attending AXS25 SUMMIT April 27 – May 1, 2025

April 23rd 2025

Shorla Oncology is attending the PCMA Annual Meeting March 10-11 2025

March 10th 2025

Audrene Rice, Our R&D Pipeline and Portfolio Manager, is attending Bio-Europe from March 17-19 in Milan, Italy

March 10th 2025

Shorla Oncology Announces Expansion of U.S. Commercial Footprint with Launch of Dedicated Sales Force and Market Access Teams

March 4th 2025

We are delighted to be recognised as a Best Workplace by Great Place to Work

February 27th 2025

Sharon and Orlaith were recently awarded the Irish Times Future Leaders award

February 24th 2025

We are attending the JP Morgan Healthcare Conference 2025 in San Francisco January 13-16. We look forward to meeting you there.

December 9th 2024

Shorla Oncology co-founders win EY Entrepreneurs of the Year award

December 2nd 2024

Shorla Oncology develops and commercializes innovative oncology drugs, where existing treatments are limited, in shortage or inadequate.

November 26th 2024